These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22819579)

  • 1. Quantitative assessment of dynamic PET imaging data in cancer imaging.
    Muzi M; O'Sullivan F; Mankoff DA; Doot RK; Pierce LA; Kurland BF; Linden HM; Kinahan PE
    Magn Reson Imaging; 2012 Nov; 30(9):1203-15. PubMed ID: 22819579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
    Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
    J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.
    Doot RK; Thompson T; Greer BE; Allberg KC; Linden HM; Mankoff DA; Kinahan PE
    Magn Reson Imaging; 2012 Nov; 30(9):1291-300. PubMed ID: 22795929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
    Gámez-Cenzano C; Pino-Sorroche F
    PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic threshold for radiation target volume by PET/CT.
    Wong CY; Mahajan P; Yan D
    J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
    [No Abstract]   [Full Text] [Related]  

  • 8. Image change detection using paradoxical theory for patient follow-up quantitation and therapy assessment.
    David S; Visvikis D; Quellec G; Le Rest CC; Fernandez P; Allard M; Roux C; Hatt M
    IEEE Trans Med Imaging; 2012 Sep; 31(9):1743-53. PubMed ID: 22614573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
    Dimitrakopoulou-Strauss A; Strauss L
    Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
    Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative PET in the 2020s: a roadmap.
    Meikle SR; Sossi V; Roncali E; Cherry SR; Banati R; Mankoff D; Jones T; James M; Sutcliffe J; Ouyang J; Petibon Y; Ma C; El Fakhri G; Surti S; Karp JS; Badawi RD; Yamaya T; Akamatsu G; Schramm G; Rezaei A; Nuyts J; Fulton R; Kyme A; Lois C; Sari H; Price J; Boellaard R; Jeraj R; Bailey DL; Eslick E; Willowson KP; Dutta J
    Phys Med Biol; 2021 Mar; 66(6):06RM01. PubMed ID: 33339012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR.
    Mérida I; Reilhac A; Redouté J; Heckemann RA; Costes N; Hammers A
    Phys Med Biol; 2017 Apr; 62(7):2834-2858. PubMed ID: 28181479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling familywise error rate for matched subspace detection in dynamic FDG PET.
    Li Z; Li Q; Pantazis D; Yu X; Conti PS; Leahy RM
    IEEE Trans Med Imaging; 2009 Oct; 28(10):1623-31. PubMed ID: 19783499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT imaging in cancer: current applications and future directions.
    Farwell MD; Pryma DA; Mankoff DA
    Cancer; 2014 Nov; 120(22):3433-45. PubMed ID: 24947987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
    Iagaru A; Mittra E; Mosci C; Dick DW; Sathekge M; Prakash V; Iyer V; Lapa P; Isidoro J; de Lima JM; Gambhir SS
    J Nucl Med; 2013 Feb; 54(2):176-83. PubMed ID: 23243299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards enhanced PET quantification in clinical oncology.
    Zaidi H; Karakatsanis N
    Br J Radiol; 2018 Jan; 91(1081):20170508. PubMed ID: 29164924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.